Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:e95

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, K.
Right arrow Articles by Böhm, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, K.
Right arrow Articles by Böhm, T.
Related Collections
Right arrow Growth factors/cytokines
Right arrow Catheter-based coronary interventions: stents

(Circulation. 1999;100:e95.)
© 1999 American Heart Association, Inc.


Circulation Electronic Pages

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

Kornél Simon, MD; Éva Öry, MD; Tamás Böhm, MD

From St. George’s Hospital, II Department of Internal Medicine, Seregélyesi, Hungary


*    To the Editor:
up arrowTop
*To the Editor:
down arrowReferences
 
We congratulate Liuzzo et al on the recent publication of their study,1 which suggests that disruption of culprit coronary stenoses by PTCA does not necessarily lead to an increase in the level of systemic inflammatory markers (C-reactive protein [CRP], serum amyloid A protein [SAA], and interleukin-6 [IL-6]) in patients with unstable angina. The authors found that serum levels of CRP, SAA, and IL-6 did not change after PTCA in unstable angina patients with normal pre-PTCA (basal) levels but that they significantly increased in those with raised pre-PTCA values. Surprisingly, the authors demonstrated that coronary arteriography also evoked a detectable transient elevation of CRP, SAA, and IL-6 serum levels in unstable angina patients with high basal values. Pre-PTCA and pre–coronary arteriography serum levels of CRP and SAA closely correlated with the corresponding postintervention peak values of both PTCA and coronary arteriography.

As the authors emphasize, it is well documented that elevated levels of acute-phase proteins are associated with an unfavorable short- and long-term prognosis in patients with coronary artery disease2 3 4 ; conversely, patients with CRP levels within the normal range tend to have a better prognosis.5 In light of these data, it would be interesting to know whether the 2 well-matched subgroups of study patients with unstable angina, ie, those with versus those without acute-phase protein response, show the same or different clinical stability and/or therapeutic responsiveness in the pre- and post-PTCA periods. Furthermore, because coronary arteriography could also trigger additional acute-phase protein elevation in a significant proportion of patients with unstable angina, should this transient moderate increase of systemic inflammatory response after coronary arteriography (like PTCA) also be considered a marker for instability of culprit coronary lesions in unstable angina patients with raised basal levels of acute-phase protein?


*    References
up arrowTop
up arrowTo the Editor:
*References
 

  1. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, Altamura S, Ciliberto G, Rebuzzi AG, Crea F, Pepys MB, Maseri A. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998;98:2370–2376.[Abstract/Free Full Text]
  2. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. Prognostic value of C-reactive protein and plasma amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417–424.[Abstract/Free Full Text]
  3. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635–641.[Abstract/Free Full Text]
  4. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462–466.[Medline] [Order article via Infotrieve]
  5. Ridker PM, Cushman M, Stamper MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, K.
Right arrow Articles by Böhm, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, K.
Right arrow Articles by Böhm, T.
Related Collections
Right arrow Growth factors/cytokines
Right arrow Catheter-based coronary interventions: stents